We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
+18.68%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$6.69B
AUM Growth
+$682M
Cap. Flow
-$395M
Cap. Flow %
-5.9%
Top 10 Hldgs %
54.02%
Holding
678
New
246
Increased
85
Reduced
72
Closed
235

Top Buys

Rank Stock Value
1
NBIX icon
Neurocrine Biosciences
NBIX
+$85.8M
2
INDV icon
Indivior Pharmaceuticals
INDV
+$59.6M
3
BCAX
Bicara Therapeutics
BCAX
+$45.8M
4
MRUS
Merus
MRUS
+$34.4M
5
VTRS icon
Viatris
VTRS
+$30M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$102M
2
SGRY icon
Surgery Partners
SGRY
+$86.4M
3
CPRX
Catalyst Pharmaceutical
CPRX
+$53.7M
4
IART icon
Integra LifeSciences
IART
+$42.8M
5
BNTX icon
BioNTech
BNTX
+$38.6M

Sector Composition

Rank Sector Weight
1 Healthcare 87.45%
2 Industrials 0.73%
3 Technology 0.55%
4 Financials 0.45%
5 Consumer Discretionary 0.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KWR icon
176
Quaker Houghton
KWR
$2.63B
$831K 0.01%
4,935
-8,080
-62% -$1.37M
VREX icon
177
Varex Imaging
VREX
$463M
$830K 0.01%
69,617
+3,724
+6% +$47.4K
TFSL icon
178
TFS Financial
TFSL
$5.07B
$826K 0.01%
+64,210
New +$846K
PPG icon
179
PPG Industries
PPG
$26.4B
$823K 0.01%
+6,216
New +$785K
NKE icon
180
Nike
NKE
$62.5B
$823K 0.01%
+9,310
New +$730K
OI icon
181
O-I Glass
OI
$1.41B
$822K 0.01%
+62,673
New +$751K
MODV
182
DELISTED
ModivCare
MODV
$809K 0.01%
56,686
+48,850
+623% +$1.12M
ORIC icon
183
Oric Pharmaceuticals
ORIC
$1.24B
$804K 0.01%
+78,435
New +$776K
SMP icon
184
Standard Motor Products
SMP
$867M
$804K 0.01%
+24,213
New +$756K
ZBH icon
185
Zimmer Biomet
ZBH
$17.8B
$799K 0.01%
7,403
+406
+6% +$44.3K
PGNY icon
186
Progyny
PGNY
$2.47B
$797K 0.01%
47,535
+31,726
+201% +$761K
STRA icon
187
Strategic Education
STRA
$1.78B
$796K 0.01%
8,604
+5,055
+142% +$511K
UBER icon
188
Uber
UBER
$139B
$787K 0.01%
10,476
-2,233
-18% -$157K
TWO
189
Two Harbors Investment
TWO
$1.27B
$785K 0.01%
+56,550
New +$771K
COR icon
190
Cencora
COR
$60.5B
$784K 0.01%
+3,485
New +$809K
MRVL icon
191
Marvell Technology
MRVL
$170B
$782K 0.01%
10,840
+7,485
+223% +$517K
ESE icon
192
ESCO Technologies
ESE
$8.4B
$780K 0.01%
+6,044
New +$712K
AQST icon
193
Aquestive Therapeutics
AQST
$468M
$773K 0.01%
155,145
+8,990
+6% +$35K
OMCL icon
194
Omnicell
OMCL
$1.89B
$770K 0.01%
17,651
-13,823
-44% -$521K
CRM icon
195
Salesforce
CRM
$142B
$768K 0.01%
2,806
+1,217
+77% +$312K
AMAL icon
196
Amalgamated Financial
AMAL
$1.46B
$762K 0.01%
24,294
-20,203
-45% -$613K
PMT
197
PennyMac Mortgage Investment
PMT
$839M
$759K 0.01%
53,221
+2,716
+5% +$37.9K
KRYS icon
198
Krystal Biotech
KRYS
$10.4B
$758K 0.01%
4,166
+2,561
+160% +$494K
RSG icon
199
Republic Services
RSG
$66.7B
$757K 0.01%
+3,771
New +$759K
PEBO icon
200
Peoples Bancorp
PEBO
$1.46B
$752K 0.01%
+25,004
New +$775K
6 7
8
9 10

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q3 2024 Portfolio in Review

As of Q3 2024, Deerfield Management held 678 positions worth $6.69B, up 11% from $6.01B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Deerfield Management withdrew a net $395M in Q3 2024, closing 235 positions and reducing 72 holdings. Its most notable exit was Gilead Sciences, an estimated $102M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 87% of assets, up from 83% a quarter earlier, followed by Industrials and Technology.

Against the trend, Deerfield Management opened a new position in Indivior Pharmaceuticals worth $49.7M.

  • Deerfield Management's largest Q3 2024 buy was Indivior Pharmaceuticals: 5,092,642 shares worth $49.7M.
  • Deerfield Management added most to Neurocrine Biosciences in Q3 2024, an estimated $85.8M increase.
  • Deerfield Management's biggest Q3 2024 reduction was Surgery Partners, cutting an estimated $86.4M.
  • Deerfield Management fully exited Gilead Sciences in Q3 2024, selling an estimated $102M.
  • Deerfield Management's ten largest holdings make up 54% of its $6.69B portfolio in Q3 2024.
  • Deerfield Management opened 246 new positions and closed 235 in Q3 2024.
  • Deerfield Management's portfolio value rose 11% quarter-over-quarter to $6.69B.

Based on Deerfield Management's 13F filing for Q3 2024, filed 14 Nov 2024.